Finance
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Device prices plunge as hospitals pay less to fix hearts

Bloomberg, September 24, 2013
Prices paid in the U.S. for medical devices, including those that regulate the heart's rhythm and replacements for hips and knees, have plunged as much as one-third since 2007 as hospitals clamped down on spending. The average inflation-adjusted prices for seven of the largest categories of medical devices fell through 2011, according to a study released today from the Advanced Medical Technology Association. Drug-coated stents used to prop open arteries sold by Boston Scientific Corp. (BSX), Abbott Laboratories (ABT) and Medtronic Inc. (MDT) had a 34 percent decline. Artificial knees from Johnson & Johnson (JNJ), Zimmer Holdings Inc. (ZMH) and Stryker Corp. (SYK) fell the least at 17 percent.